Literature for inhibitor I27.001: calpastatin inhibitor unit 1

(Topics flags: S Structure, I Inhibitor, E Expression. To select only the references relevant to a single topic, click the link above. See explanation.)

2019
1. Biswas,A.K. and Tandon,S.
   Single-step purification of calpain-1, calpain-2, and calpastatin using anion-exchange chromatography
   Methods Mol Biol (2019) 1915, 3-11. PubMed  Europe PubMed DOI
2018
2. Nguyen,H.H., Volkov,A.N., Vandenbussche,G., Tompa,P. and Pauwels,K.
   In vivo biotinylated calpastatin improves the affinity purification of human m-calpain
   Protein Expr Purif (2018) 145, 77-84. PubMed  Europe PubMed DOI
2010
3. Jiao,W., McDonald,D.Q., Coxon,J.M. and Parker,E.J.
   Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain
   Biochemistry (2010) 49, 5533-5539. PubMed  Europe PubMed DOI
2008
4. Croall,D.E., Vanhooser,L.M. and Cashon,R.E.
   Detecting the active conformation of calpain with calpastatin-based reagents
   Biochim Biophys Acta (2008) 1784, 1676-1686. PubMed  Europe PubMed DOI  PMC  EPMC
5. Moldoveanu,T., Gehring,K. and Green,D.R.
   Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains
   Nature (2008) 456, 404-408. PubMed  Europe PubMed DOI  S
6. Pfizer,J., Assfalg-Machleidt,I., Machleidt,W. and Schaschke,N.
   Inhibition of human mu-calpain by conformationally constrained calpastatin peptides
   Biol Chem (2008) 389, 83-90. PubMed  Europe PubMed DOI
2005
7. [YEAR:15-3-2005]Csizmok,V., Bokor,M., Banki,P., Klement,E., Medzihradszky,K.F., Friedrich,P., Tompa,K. and Tompa,P.
   Primary contact sites in intrinsically unstructured proteins: the case of calpastatin and microtubule-associated protein 2
   Biochemistry (15-3-2005) 44, 3955-3964. PubMed  Europe PubMed DOI
2004
8. Wendt,A., Thompson,V.F. and Goll,D.E.
   Interaction of calpastatin with calpain: a review
   Biol Chem (2004) 385, 465-472. PubMed  Europe PubMed DOI
2003
9. [YEAR:7-3-2003]Betts,R., Weinsheimer,S., Blouse,G.E. and Anagli,J.
   Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT
   J Biol Chem (7-3-2003) 278, 7800-7809. PubMed  Europe PubMed DOI  I
10. Gil-Parrado,S., Assfalg-Machleidt,I., Fiorino,F., Deluca,D., Pfeiler,D., Schaschke,N., Moroder,L. and Machleidt,W.
    Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin
    Biol Chem (2003) 384, 395-402. PubMed  Europe PubMed DOI  I
11. Popp,O., Heidinger,M., Ruiz-Heinrich,L., Ries,C., Jochum,M. and Gil-Parrado,S.
    The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells
    Biol Chem (2003) 384, 951-958. PubMed  Europe PubMed DOI
12. [YEAR:18-4-2003]Todd,B., Moore,D., Deivanayagam,C.C., Lin,G.D., Chattopadhyay,D., Maki,M., Wang,K.K. and Narayana,S.V.
    A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor
    J Mol Biol (18-4-2003) 328, 131-146. PubMed  Europe PubMed DOI  S  I
2002
13. [YEAR:15-3-2002]Tompa,P., Mucsi,Z., Orosz,G. and Friedrich,P.
    Calpastatin subdomains A and C are activators of calpain
    J Biol Chem (15-3-2002) 277, 9022-9026. PubMed  Europe PubMed DOI
2000
14. Li,S., Liang,Z.G., Wang,G.Y., Yavetz,B., Kim,E.D. and Goldberg,E.
    Molecular cloning and characterization of functional domains of a human testis-specific isoform of calpastatin
    Biol Reprod (2000) 63, 172-178. PubMed  Europe PubMed
15. Li,S. and Goldberg,E.
    A novel N-terminal domain directs membrane localization of mouse testis-specific calpastatin
    Biol Reprod (2000) 63, 1594-1600. PubMed  Europe PubMed
16. Takano,J., Watanabe,M., Hitomi,K. and Maki,M.
    Four types of calpastatin isoforms with distinct amino-terminal sequences are specified by alternative first exons and differentially expressed in mouse tissues
    J Biochem (2000) 128, 83-92. PubMed  Europe PubMed
1999
17. Nakamura,Y., Fukiage,C., Ma,H., Shih,M., Azuma,M. and Shearer,T.R.
    Decreased sensitivity of lens-specific calpain Lp82 to calpastatin inhibitor
    Exp Eye Res (1999) 69, 155-162. PubMed  Europe PubMed DOI  I
1998
18. [YEAR:29-5-1998]Hitomi,K., Uchiyama,Y., Ohkubo,I., Kunimatsu,M., Sasaki,M. and Maki,M.
    Purification and characterization of the active-site-mutated recombinant human mu-calpain expressed in baculovirus-infected insect cells
    Biochem Biophys Res Commun (29-5-1998) 246, 681-685. PubMed  Europe PubMed DOI  E
1991
19. Ishima,R., Tamura,A., Akasaka,K., Hamaguchi,K., Makino,K., Murachi,T., Hatanaka,M. and Maki,M.
    Structure of the active 27-residue fragment of human calpastatin
    FEBS Lett (1991) 294, 64-66. PubMed  Europe PubMed DOI  S
1987
20. Maki,M., Takano,E., Mori,H., Sato,A., Murachi,T. and Hatanaka,M.
    All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II
    FEBS Lett (1987) 223, 174-180. PubMed  Europe PubMed